Delstrigo (doravirine/lamuvidine/tenofovir disoproxil fumarate)

pCPA File Number: 21115
Negotiation Status:
Concluded with an LOI
Indication(s):
HIV-1 Infection
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SR0581-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: